|
|
|
Insider
Information: |
Ecor1 Capital, Llc |
Relationship: |
10% Owner |
City: |
San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
242,348,918 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$1,138,943,956 |
|
|
Total
Shares |
242,348,918 |
|
|
Total
Value |
$1,138,943,956 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
3
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
1
|
2
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-100.0%
|
-5.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Celladon Corp |
CLDN |
10% Owner |
|
0 |
2015-06-26 |
2,843,170 |
Premium* |
|
Prothena Corp Plc |
PRTA |
10% Owner |
|
0 |
2022-05-05 |
11,584,280 |
Premium* |
|
Surface Oncology, Inc. |
SURF |
10% Owner |
|
0 |
2020-09-01 |
4,701,081 |
Premium* |
|
Akouos, Inc. |
AKUS |
10% Owner |
2020-06-30 |
0 |
2020-06-30 |
1,975,984 |
Premium* |
|
Anaptysbio Inc |
ANAB |
10% Owner |
|
0 |
2024-08-14 |
7,794,996 |
Premium* |
|
Corvus Pharmaceuticals, Inc. |
CRVS |
10% Owner |
|
0 |
2021-10-01 |
81,077 |
Premium* |
|
Odonate Therapeutics Inc |
ODT |
10% Owner |
|
0 |
2021-12-10 |
0 |
Premium* |
|
Voyager Therapeutics, Inc. |
VYGR |
10% Owner |
|
0 |
2023-01-11 |
3,851,507 |
Premium* |
|
Tscan Therapeutics, Inc. |
TCRX |
10% Owner |
|
0 |
2023-05-26 |
5,000,000 |
Premium* |
|
Mersana Therapeutics, Inc. |
MRSN |
10% Owner |
|
0 |
2023-07-27 |
19,364,688 |
Premium* |
|
Tango Therapeutics Ord Shs |
TNGX |
10% Owner |
|
0 |
2023-10-13 |
13,330,736 |
Premium* |
|
Mirati Therapeutics, Inc. |
MRTX |
10% Owner |
|
0 |
2023-12-18 |
7,396,979 |
Premium* |
|
Adaptimmune Therapeutics PLC |
ADAP |
10% Owner |
|
0 |
2024-03-08 |
164,424,420 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
41 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CLDN |
Celladon Corp |
10% Owner |
|
2015-06-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,843,170 |
|
- |
|
PRTA |
Prothena Corp Plc |
10% Owner |
|
2019-08-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,426,640 |
|
- |
|
SURF |
Surface Oncology, Inc. |
10% Owner |
|
2020-05-19 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,033,861 |
|
- |
|
AKUS |
Akouos, Inc. |
10% Owner |
|
2020-06-30 |
4 |
B |
$17.00 |
$19,992,000 |
I/I |
1,176,000 |
1,975,984 |
1.5 |
- |
|
AKUS |
Akouos, Inc. |
10% Owner |
|
2020-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
799,984 |
799,984 |
0 |
- |
|
SURF |
Surface Oncology, Inc. |
10% Owner |
|
2020-09-01 |
4 |
S |
$7.14 |
$2,376,681 |
I/I |
(332,780) |
4,701,081 |
0 |
- |
|
ANAB |
Anaptysbio Inc |
10% Owner |
|
2021-01-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,813,324 |
|
- |
|
PRTA |
Prothena Corp Plc |
10% Owner |
|
2021-02-12 |
4 |
B |
$20.08 |
$6,959,761 |
I/I |
345,300 |
9,771,940 |
1.5 |
- |
|
PRTA |
Prothena Corp Plc |
10% Owner |
|
2021-02-16 |
4 |
B |
$22.78 |
$2,031,967 |
I/I |
89,200 |
9,861,140 |
1.5 |
- |
|
PRTA |
Prothena Corp Plc |
10% Owner |
|
2021-02-17 |
4 |
B |
$23.46 |
$4,665,542 |
I/I |
198,840 |
10,059,980 |
1.5 |
- |
|
PRTA |
Prothena Corp Plc |
10% Owner |
|
2021-02-18 |
4 |
B |
$3.68 |
$162,103 |
I/I |
44,100 |
10,104,080 |
1.5 |
- |
|
ANAB |
Anaptysbio Inc |
10% Owner |
|
2021-02-23 |
4 |
B |
$25.48 |
$751,657 |
I/I |
29,500 |
3,842,824 |
1.5 |
- |
|
PRTA |
Prothena Corp Plc |
10% Owner |
|
2021-02-23 |
4 |
B |
$21.05 |
$934,518 |
I/I |
44,400 |
10,148,480 |
1.5 |
- |
|
PRTA |
Prothena Corp Plc |
10% Owner |
|
2021-02-24 |
4 |
B |
$22.02 |
$237,867 |
I/I |
10,800 |
10,159,280 |
1.5 |
- |
|
ANAB |
Anaptysbio Inc |
10% Owner |
|
2021-03-08 |
4 |
B |
$18.97 |
$52,694,310 |
I/I |
2,777,800 |
6,620,624 |
1.5 |
- |
|
ANAB |
Anaptysbio Inc |
10% Owner |
|
2021-03-09 |
4 |
B |
$18.70 |
$9,928,426 |
I/I |
531,000 |
7,151,624 |
1.5 |
- |
|
PRTA |
Prothena Corp Plc |
10% Owner |
|
2021-03-24 |
4 |
B |
$20.75 |
$18,156,250 |
I/I |
875,000 |
11,034,280 |
1.5 |
- |
|
PRTA |
Prothena Corp Plc |
10% Owner |
|
2021-06-18 |
4 |
OE |
$30.00 |
$7,500,000 |
I/I |
250,000 |
11,284,280 |
0 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
10% Owner |
|
2021-09-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,081,077 |
|
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
10% Owner |
|
2021-09-30 |
4 |
S |
$5.04 |
$15,131,100 |
I/I |
(3,000,000) |
2,081,077 |
0 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
10% Owner |
|
2021-10-01 |
4 |
S |
$4.96 |
$9,928,800 |
I/I |
(2,000,000) |
81,077 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
10% Owner |
|
2021-11-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,701,669 |
|
- |
|
ODT |
Odonate Therapeutics Inc |
10% Owner |
|
2021-12-01 |
4 |
B |
$1.66 |
$308,662 |
I/I |
185,941 |
5,701,669 |
1.5 |
- |
|
ODT |
Odonate Therapeutics Inc |
10% Owner |
|
2021-12-01 |
4 |
S |
$1.66 |
$308,662 |
I/I |
(185,941) |
5,701,669 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
10% Owner |
|
2021-12-09 |
4 |
S |
$1.82 |
$284,981 |
I/I |
(156,669) |
5,545,000 |
0 |
- |
|
41 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|